COMMUNIQUÉ DE PRESSE publié le 26/10/2023 à 14:30, il y a 1 année Jaguar Health to Present November 1st at Emerging Growth Conference
COMMUNIQUÉ DE PRESSE publié le 23/10/2023 à 14:30, il y a 1 année Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
COMMUNIQUÉ DE PRESSE publié le 19/10/2023 à 14:30, il y a 1 année 1 mois Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
COMMUNIQUÉ DE PRESSE publié le 18/10/2023 à 14:30, il y a 1 année 1 mois Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
COMMUNIQUÉ DE PRESSE publié le 12/10/2023 à 14:30, il y a 1 année 1 mois Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
COMMUNIQUÉ DE PRESSE publié le 10/10/2023 à 14:30, il y a 1 année 1 mois Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:30, il y a 1 année 1 mois Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
COMMUNIQUÉ DE PRESSE publié le 27/09/2023 à 14:30, il y a 1 année 1 mois Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
COMMUNIQUÉ DE PRESSE publié le 26/09/2023 à 14:30, il y a 1 année 1 mois Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
COMMUNIQUÉ DE PRESSE publié le 21/09/2023 à 13:30, il y a 1 année 2 mois Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD
Publié le 22/11/2024 à 16:15, il y a 10 heures 51 minutes NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 21/11/2024 à 06:58, il y a 1 jour 20 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 22/11/2024 à 23:55, il y a 3 heures 11 minutes Boron One Announces Early Warrant Exercise Incentive Program
Publié le 22/11/2024 à 23:30, il y a 3 heures 36 minutes Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Publié le 22/11/2024 à 23:05, il y a 4 heures 1 minute Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Publié le 22/11/2024 à 22:30, il y a 4 heures 36 minutes Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Publié le 22/11/2024 à 18:14, il y a 8 heures 51 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/11/2024 à 17:53, il y a 9 heures 12 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 22/11/2024 à 16:55, il y a 10 heures 10 minutes EQS-Adhoc: Comment on withdrawn non-binding offer
Publié le 22/11/2024 à 16:00, il y a 11 heures 6 minutes Proposed cancellation of admission to trading
